FDA 510(k) SOP + Substantial Equivalence Matrix — 21 CFR & QMSR (USA)
€69.00
ISO 13485 & MDSAP Ready
Editable Word & Excel
ISO 13485 / MDSAP / FDA QMSR
21 CFR · 510(k), De Novo, PMA · eSTAR
FDA Marketing Authorization Procedure and Substantial Equivalence Matrix — USA
A procedure for the US pathways from classification to registration and listing, and an Excel workbook with the pathway decision, a substantial equivalence matrix and a submission readiness checklist.
Most 510(k) problems start with the predicate comparison
FDA classification sets the route: exempt, 510(k), De Novo or PMA. For a 510(k), the substantial equivalence argument against one or more predicates is the core of the submission, and gaps in it are a common reason for refuse-to-accept decisions and requests for additional information.
This package sets out the US process, including registration and listing, UDI and change assessment, and gives you the matrix that structures the equivalence comparison.
- 1 SOP
- 1 Excel workbook
- SE matrix
- Readiness checklist
- Word and Excel
- Instant download
Scope
What the package covers
01
Pathway
Classification under 21 CFR and a decision tree for exempt, 510(k), De Novo and PMA.
02
Equivalence
A side-by-side comparison with up to three predicates on intended use, technological characteristics and performance.
03
Lifecycle
Establishment registration and listing, UDI and GUDID, and change assessment for when a new 510(k) is needed.
Contents
What is in the package
Audience
Who the package is for
- Manufacturers preparing a first 510(k)
- Regulatory teams assessing whether a change needs a new submission
- Companies adding the US to an MDSAP market set
The package assumes you run, or are setting up, an ISO 13485 quality management system that will be audited under MDSAP. It gives you the procedure and the records; the content specific to your devices and your markets is your work.
What is included
What you get when you buy
- SOP-REG-US Marketing Authorization USA procedure, Word
- F-REG-US.1 Pathway Selection + Substantial Equivalence Matrix, Excel
- Instant download after purchase
Questions
Before you buy
Can I buy the whole MDSAP set instead?
Yes. This package is one of 15 in the MDSAP Documentation Kit, which adds a user guide and a master index across all five jurisdictions. €399 against €1,035 buying the fifteen separately.
What is the licence?
One-time purchase, single-organisation licence. The files are yours to keep, rebrand and bring under your own document control.
Selling in all five MDSAP markets?
This package is one of 15 in the MDSAP kit.
The MDSAP Documentation Kit covers the shared core procedures, MDSAP programme management, and marketing authorisation and vigilance for Brazil, Japan, Canada, Australia and the USA. €399 for all fifteen; with ISO 13485, the combined kit is €699.
FDA Marketing Authorization Procedure and Substantial Equivalence Matrix — USA
A procedure for the US pathways from classification to registration and listing, and an Excel workbook with the pathway decision, a substantial equivalence matrix and a submission readiness checklist.
€69.00


